HEALTH ADVANCE INC. Inactive Instrument
Health Advance Inc. Stock Other OTC
Equities
HADV
US42225L2034
Biotechnology & Medical Research
Financials (USD)
| Sales 2015 | - | Sales 2016 | - | Capitalization | 1.23M |
|---|---|---|---|---|---|
| Net income 2015 | - | Net income 2016 | - | EV / Sales 2015 | - |
| Net Debt 2015 | 72.77K | Net Debt 2016 | 98.54K | EV / Sales 2016 | - |
| P/E ratio 2015 |
-39.9
x | P/E ratio 2016 |
-41.6
x | Employees | - |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 39.05% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
Health Advance, Inc. is focused on cannabidiol (CBD) infused dealcoholized wine beverage products and a new nutraceutical product range. Its principal products or services include CBD infused dealcoholized wine and immune boosting nutraceutical in pre-production. The Companyâs subsidiary is Courtship Wines, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.78% | 43.43B | |
| +47.92% | 41.69B | |
| +7.72% | 41.31B | |
| -10.82% | 27.14B | |
| +9.04% | 25.28B | |
| -24.87% | 18.47B | |
| +33.55% | 12.59B | |
| +1.10% | 12.33B | |
| +8.79% | 11.03B |
